Newborn Advantage Surrogacy, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Newborn Advantage Surrogacy, LLC - overview
Established
2005
Location
Dallas, TX, US
Primary Industry
Healthcare
About
Newborn Advantage is a dedicated surrogacy agency specializing in gestational surrogacy, facilitating connections between intended parents and vetted surrogate candidates to help create families. Newborn Advantage Surrogacy, LLC was founded in 2005 and operates out of Dallas, US. The company focuses on providing gestational surrogacy services, offering a streamlined matching process that pairs clients with surrogate candidates efficiently. In August 2020, Newborn Advantage was acquired by Santa Monica Fertility, a portfolio company of Webster Equity Partners, although financial terms were not disclosed.
The founder of Newborn Advantage has not been publicly detailed, nor are any prior ventures known. Newborn Advantage is a leading surrogacy agency that focuses on providing gestational surrogacy services to intended parents. Their core offerings include a streamlined matching process that connects clients with carefully vetted surrogate candidates within two weeks, significantly faster than many competitors in the market. The agency emphasizes the importance of genetics and the birthing environment in securing a successful outcome for newborns, thereby conducting rigorous psychological and medical evaluations of surrogate candidates.
This vetting process ensures that intended parents are matched with high-quality surrogates who meet strict requirements. Newborn Advantage caters primarily to intended parents across the United States, including families seeking surrogates for medical, personal, or lifestyle reasons, as well as LGBTQ+ couples looking to start or expand their families. Newborn Advantage generates revenue through direct service fees associated with their surrogacy matching process. Clients engage the agency for services that include consultations, surrogate matching, and ongoing support throughout the surrogacy journey, paying a fee that reflects the agency's comprehensive support from initial consultations to the legal and medical processes involved in surrogacy.
The agency's flagship service, the rapid matching of high-quality surrogate candidates, uniquely positions it within the market, attracting a diverse clientele seeking effective solutions to their surrogacy needs. Following the acquisition in August 2020, Newborn Advantage plans to leverage new resources for expansion and improvement of their services. The company is focused on enhancing their matching system and exploring opportunities to enter markets beyond the United States. Recent funding from the acquisition aims to support new technology developments and improve client outreach efforts.
Specific timelines for new product launches and geographic expansion have not been disclosed.
Current Investors
Santa Monica Fertility
Primary Industry
Healthcare
Sub Industries
Hospitals
Website
www.newbornadvantage.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Newborn Advantage Surrogacy, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Newborn Advantage Surrogacy, LLC | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.